4th Quarter - Termination — THE CONAFAY GROUP, LLC for CEMPRA PHARMACEUTICALS (2017)

Firm

THE CONAFAY GROUP, LLC

Client

CEMPRA PHARMACEUTICALS

Income

$20,000

Expenses

—

Terminated

Oct 31, 2017

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare policies involving antibiotics to treat resistant pathogens.

Lobbyist	Covered position, as disclosed
STEPHEN R CONAFAY	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA Reform

Lobbyist	Covered position, as disclosed
STEPHEN R CONAFAY	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.